Amoxicillin

Uses

Benefits

Dosage & preparation

Comparisons

Evidence quality

Highlighted claims

• WHO recommends amoxicillin as a first-choice antibiotic for mild or moderate bacterial CAP in adults and for non-severe pneumonia in children. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
• The review included 27 amoxicillin trials with 39,968 patients. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
• Random-effects models found no strong evidence that amoxicillin differed from other antibiotics for clinical resolution. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
• Clinical failure evidence for amoxicillin versus other antibiotics was unclear and did not exclude important benefit or harm. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
• Placebo-controlled trials in young children with non-severe CAP found a clinical benefit for amoxicillin. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
• Adult amoxicillin regimens varied widely in duration and daily dose across studies. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis